Autoimmune-Related Chest Pain: Causes
Autoimmune-related chest pain stems from three primary mechanisms: pericardial inflammation (pericarditis/myopericarditis), interstitial lung disease causing pleuritic pain and dyspnea, and coronary microvascular dysfunction causing ischemic chest pain without obstructive coronary disease.
Primary Mechanisms by Autoimmune Disease
Pericardial/Myocardial Involvement
The pericardium is commonly affected in systemic autoimmune diseases, manifesting as either symptomatic pericarditis with positional chest pain or asymptomatic effusion 1. This occurs in:
- Systemic lupus erythematosus (SLE)
- Rheumatoid arthritis
- Systemic sclerosis
- Mixed connective tissue disease
- Sjögren's syndrome
The mechanism involves autoantibodies against cardiac antigens (such as anti-β1 adrenoceptor antibodies) triggering inflammatory responses 2. Idiopathic recurrent pericarditis represents primary dysfunction of the innate immune system, mimicking hereditary periodic fever syndromes 1.
Interstitial Lung Disease (ILD)
ILD is a major cause of chest pain and represents the leading cause of death in systemic sclerosis, affecting >50% of adults with this condition 3. The inflammation and fibrosis of lung parenchyma causes:
- Pleuritic chest pain
- Dyspnea
- Progressive respiratory symptoms
High-risk populations include those with:
- Systemic sclerosis: Anti-Scl-70 positivity, diffuse cutaneous subtype, male sex, African American race, early disease (first 5-7 years)
- Rheumatoid arthritis: High-titer RF/anti-CCP, smoking history, older age at onset, male sex
- Idiopathic inflammatory myopathies: Anti-synthetase syndrome, dermatomyositis, polymyositis
- Mixed connective tissue disease and Sjögren's disease 3
Coronary Microvascular Dysfunction
Approximately half of SLE patients with chest pain and no obstructive coronary disease have coronary microvascular dysfunction (CMD) 4. This represents ischemia with no obstructive coronary arteries (INOCA), causing:
- Anginal chest pain
- Exercise intolerance
- Elevated cardiovascular mortality
The mechanism involves chronic inflammation affecting coronary microvasculature rather than epicardial vessels 4, 5.
Diagnostic Approach
For Suspected ILD-Related Chest Pain:
Screen with pulmonary function tests (PFTs) and high-resolution CT chest (HRCT) as conditionally recommended by 2023 ACR/CHEST guidelines 3. Avoid:
- Chest radiography (inadequate sensitivity)
- 6-minute walk test for screening
- Bronchoscopy or surgical lung biopsy (strongly recommended against for screening)
For Suspected Pericarditis:
Look for:
- Positional chest pain (worse supine, relieved sitting forward)
- Elevated troponin, ESR, C-reactive protein
- Cardiac MRI showing pericardial hyperenhancement and myocardial edema 6
- Autoantibody testing (ANA, anti-Sjögren's antibodies, cardiac-specific autoantibodies)
For Suspected CMD:
Evaluate in SLE patients with:
- Typical anginal symptoms
- Normal coronary angiography
- Elevated cardiovascular risk markers
- Consider advanced coronary physiology testing 4
Critical Pitfalls
Do not attribute chest pain solely to anxiety or non-cardiac causes in autoimmune disease patients without proper evaluation—these conditions carry significantly elevated cardiovascular morbidity and mortality 5. The mechanistic link between chronic inflammation and cardiovascular/pulmonary pathology is well-established but often underrecognized in clinical practice.
Rapidly progressive ILD can occur in RA, SSc, IIM, MCTD, and SjD 3—maintain high suspicion and low threshold for HRCT imaging in high-risk patients presenting with new chest pain and dyspnea.
For pericarditis, corticosteroid responsiveness supports autoimmune etiology when viral serologies are negative 2, though treatment recommendations vary by specific autoimmune condition 7.